Contemporary Concepts in Prostate Cancer is an online resource for professionals within the oncology space, from medical oncologists and pathologists to oncology nurses and mental health experts. Prostate cancer is the most common cancers in men within the United States beyond skin cancer, and is most likely to develop in older and non–Hispanic Black men. Due to this, CancerNetwork® has created a central hub to inform oncology professionals about the latest non-clinical developments in patient care. Contemporary Concepts in Prostate Cancer also provides the most recent findings regarding patient-specific issues such as the psychosocial impact of prostate cancer, sexual health, disparities in care and outcomes, survivorship and quality of life, and financial toxicity.
Contemporary Concepts in Prostate Cancer showcases articles, podcasts, and video interviews with key opinion leaders in the field to keep you up to date with the latest developments in the prostate oncology space.
CancerNetwork® sat down with Alicia Morgans MD, MPH, at the 2021 European Society for Medical Oncology to discuss how a hypothetical cohort from the CARD trial highlighted the impact of treatment with cabazitaxel on costs and complications in patients with metastatic castration-resistant prostate cancer.
A health-related quality of life assessment found an association between worsened self-reported fatigue, cognitive function, and physical function, with enzalutamide treatment for patients with metastatic, hormone-sensitive prostate cancer but improved deterioration-free survival for overall health and quality of life.